Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma

17 Oct 2022

Abstract excerpt

Lower-grade glioma (LGG) is a common malignant primary tumour in the central nervous system, and most patients eventually develop highly aggressive gliomas despite comprehensive traditional treatment. Tumour molecular subtypes and prognostic biomarkers play a crucial role in LGG diagnosis and treatment. Therefore, the identification of novel biomarkers in LGG patients is crucial for predicting the prognosis of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36325335
DOI: 10.3389/fimmu.2022.1011757

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade gliomaPMID 36325335Read ↗

Diverse cell death signature based subtypes predict the prognosis and immune characteristics within gliomaSemantic proximity Read ↗

Leveraging a diverse cell-death patterns-based signature to predict the prognosis of low- grade gliomasSemantic proximity Read ↗

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade GliomasSemantic proximity Read ↗

Diverse cell death signature based subtypes predict the prognosis and immune characteristics within gliomaSemantic proximity Read ↗

Tumor antigens and immunogenic cell death subtypes guided mRNA vaccine development for lower-grade gliomasSemantic proximity Read ↗

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade GliomaSemantic proximity Read ↗

Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in GliomaSemantic proximity Read ↗

Clinical and Biological Significance of a Necroptosis-Related Gene Signature in GliomaSemantic proximity Read ↗

Immunogenic Cell Death-related Signature Evaluates the Tumor Microenvironment and Predicts the Prognosis in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Development of a prognostic model of glioma based on immune‑related genesSemantic proximity Read ↗

A Pyroptosis-Related Gene Signature Associated with Prognosis and Tumor Immune Microenvironment in GliomasSemantic proximity Read ↗

A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.